Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 103, 104186
Abstract
No abstract availableKeywords
Funding Information
- Biotechnology Research Center, Tabriz University of Medical Sciences
This publication has 78 references indexed in Scilit:
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important LigandsJournal of Medicinal Chemistry, 2012
- Interactions of AChE with A? Aggregates in Alzheimer?s Brain: Therapeutic Relevance of IDN 5706Frontiers in Molecular Neuroscience, 2011
- A qualitative approach to enzyme inhibitionBiochemistry and Molecular Biology Education, 2009
- Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of ActionChemBioChem, 2007
- General and targeted statistical potentials for protein–ligand interactionsProteins: Structure, Function, and Bioinformatics, 2005
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils 1 1Edited by A. R. FershtJournal of Molecular Biology, 1997
- p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical StructureJournal of the American Chemical Society, 1964
- The Effect of Structure upon the Reactions of Organic Compounds. Benzene DerivativesJournal of the American Chemical Society, 1937